• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗2019冠状病毒病的临床和流行病学特征:一项基于医院的观察性研究。

Clinical and Epidemiological Characteristics of Coronavirus Disease 2019 in Iran: a Hospital-Based Observational Study.

作者信息

Darazam Ilad Alavi, Besharati Sajad, Shabani Minoosh, Shokouhi Shervin, Fallahzadeh Mohammad, Shabanpour Dehbsneh Hadiseh, Khalili Negar, Soleymaninia Azam, Hoseyni Kusha Akram, Taleb Shoushtari Maryam, Amirdosara Mahdi, Hajiesmaeili Mohammadreza, Rezaei Omidvar, Khoshkar Ali, Naghibi Irvani Seyed Sina, Kheyrian Mahnaz, Goudarzi Fatemeh

机构信息

Clinical Research Development Unit of Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Tanaffos. 2021 Feb;20(2):156-163.

PMID:34976087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8710226/
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) has been pandemic and has caused a great burden on almost all countries across the world. Different perspectives of this novel disease are poorly understood. This study sought to investigate the clinical and epidemiological characteristics of COVID-19 to efficiently assist the health system of Iran to conquer the outbreak.

MATERIALS AND METHODS

This retrospective observational study was performed on 394 patients with a diagnosis of COVID-19. The patients should have a history of hospitalization at Loghman-Hakim hospital, Tehran, Iran, for 10 weeks, beginning from the first official report of the disease in Iran. In the subsequent step, the baseline demographic and clinical and paraclinical information of the patients was documented. Finally, the patients were assessed if they had exhibited any morbidity or mortality.

RESULTS

The epidemiological examination of the COVID-19 population suggested a bell diagram pattern for the hospitalization rate, in which the 4th week of the study was the peak. The highest rate of secondary adverse events due to the virus was observed at the 6th and 7th weeks of the study course. On another note, clinical evaluations resulted in identifying specific abnormalities, such as bilateral opacity in chest computed tomography scans or low oxygen saturation in laboratory data.

CONCLUSION

This study provides evidence concerning the clinical and epidemiological characteristics of COVID-19 in the first phase of the virus outbreak in Iran. Further studies comparing the disease features in the subsequent phases with findings of this study can pave the way for additional information in this regard.

摘要

背景

2019年冠状病毒病(COVID-19)已成为大流行病,给世界上几乎所有国家都带来了巨大负担。人们对这种新型疾病的不同方面了解甚少。本研究旨在调查COVID-19的临床和流行病学特征,以有效协助伊朗的卫生系统控制疫情。

材料与方法

本回顾性观察研究对394例确诊为COVID-19的患者进行。这些患者应自伊朗首次官方报告该疾病起,在伊朗德黑兰的洛格曼-哈基姆医院有10周的住院史。接下来,记录患者的基线人口统计学、临床和辅助检查信息。最后,评估患者是否出现任何发病或死亡情况。

结果

对COVID-19患者群体的流行病学检查显示住院率呈钟形图模式,其中研究的第4周为峰值。在研究过程的第6周和第7周观察到由该病毒引起的继发性不良事件发生率最高。另一方面,临床评估发现了一些特定异常,如胸部计算机断层扫描中的双侧模糊影或实验室数据中的低氧饱和度。

结论

本研究提供了有关伊朗病毒爆发第一阶段COVID-19临床和流行病学特征的证据。进一步比较后续阶段疾病特征与本研究结果的研究可为这方面的更多信息铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/ad83896610e2/Tanaffos-20-156-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/a33bb24e650b/Tanaffos-20-156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/5f30f2583976/Tanaffos-20-156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/1d87428dfc37/Tanaffos-20-156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/ad83896610e2/Tanaffos-20-156-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/a33bb24e650b/Tanaffos-20-156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/5f30f2583976/Tanaffos-20-156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/1d87428dfc37/Tanaffos-20-156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/8710226/ad83896610e2/Tanaffos-20-156-g004.jpg

相似文献

1
Clinical and Epidemiological Characteristics of Coronavirus Disease 2019 in Iran: a Hospital-Based Observational Study.伊朗2019冠状病毒病的临床和流行病学特征:一项基于医院的观察性研究。
Tanaffos. 2021 Feb;20(2):156-163.
2
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.干扰素 β1a 对比干扰素 β1b 和常规治疗方案治疗中重度 COVID-19 成人患者的效果:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):473. doi: 10.1186/s13063-020-04382-3.
3
Clinical features, demographics, laboratory and imaging data of patients hospitalized with coronavirus disease 2019 (COVID-19) in Iran.伊朗 2019 冠状病毒病(COVID-19)住院患者的临床特征、人口统计学、实验室和影像学数据。
Przegl Epidemiol. 2021;75(3):326-331. doi: 10.32394/pe.75.29.
4
A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.伊朗一家转诊医院的一名新冠肺炎患者:一个典型病例。
Infect Disord Drug Targets. 2020;20(4):559-562. doi: 10.2174/1871526520666200429115535.
5
Hospital-treated intentional self-poisoning events and in-hospital mortality in Tehran before and during the COVID-19 pandemic.新冠疫情之前及期间德黑兰医院收治的蓄意自我中毒事件及院内死亡率
Curr Psychol. 2022 May 26:1-8. doi: 10.1007/s12144-022-03248-y.
6
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.高剂量干扰素β-1a与低剂量干扰素β-1a(基础治疗方案)相比对中度至重度COVID-19的有益效果研究:一项随机对照试验研究方案的结构化总结
Trials. 2020 Oct 26;21(1):880. doi: 10.1186/s13063-020-04812-2.
7
Assessing the Epidemiological Data and Management Methods of Body Packers Admitted to a Referral Center in Iran.评估伊朗一家转诊中心收治的人体藏毒者的流行病学数据及管理方法。
Medicine (Baltimore). 2016 May;95(19):e3656. doi: 10.1097/MD.0000000000003656.
8
The COVID-19 Outbreak in Iran; The First Patient with a Definite Diagnosis.伊朗的 COVID-19 疫情爆发;首例明确诊断的患者。
Arch Iran Med. 2020 Jul 1;23(7):503-504. doi: 10.34172/aim.2020.48.
9
COVID-19 Mortality in Children: A Referral Center Experience from Iran (Mofid Children's Hospital, Tehran, Iran).儿童新冠病毒肺炎死亡病例:来自伊朗(德黑兰莫菲德儿童医院)的转诊中心经验
Can J Infect Dis Med Microbiol. 2022 Mar 16;2022:2737719. doi: 10.1155/2022/2737719. eCollection 2022.
10
Prognostic Factors Associated with Survival in Patients Infected with COVID-19: A Retrospective Study on 214 Patients from Iran.与新冠病毒感染患者生存相关的预后因素:对214例伊朗患者的回顾性研究
Arch Iran Med. 2021 Apr 1;24(4):333-338. doi: 10.34172/aim.2021.47.

本文引用的文献

1
Laboratory findings of COVID-19: a systematic review and meta-analysis.COVID-19 的实验室检测结果:系统评价和荟萃分析。
Scand J Clin Lab Invest. 2020 Oct;80(6):441-447. doi: 10.1080/00365513.2020.1768587. Epub 2020 May 23.
2
Cardiovascular complications in COVID-19.COVID-19 中的心血管并发症。
Am J Emerg Med. 2020 Jul;38(7):1504-1507. doi: 10.1016/j.ajem.2020.04.048. Epub 2020 Apr 18.
3
COVID-19 pneumonia: A review of typical CT findings and differential diagnosis.COVID-19 肺炎:CT 表现的典型特征及鉴别诊断综述。
Diagn Interv Imaging. 2020 May;101(5):263-268. doi: 10.1016/j.diii.2020.03.014. Epub 2020 Apr 3.
4
Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis.新型冠状病毒病 2019(COVID-19)的 CT 表现:系统评价和荟萃分析。
J Am Coll Radiol. 2020 Jun;17(6):701-709. doi: 10.1016/j.jacr.2020.03.006. Epub 2020 Mar 25.
5
COVID-19 Pandemic and Comparative Health Policy Learning in Iran.新型冠状病毒肺炎疫情与伊朗的比较健康政策学习。
Arch Iran Med. 2020 Apr 1;23(4):220-234. doi: 10.34172/aim.2020.02.
6
Treatment for severe acute respiratory distress syndrome from COVID-19.新型冠状病毒肺炎所致严重急性呼吸窘迫综合征的治疗
Lancet Respir Med. 2020 May;8(5):433-434. doi: 10.1016/S2213-2600(20)30127-2. Epub 2020 Mar 20.
7
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的临床、实验室和影像学特征:系统评价和荟萃分析。
Travel Med Infect Dis. 2020 Mar-Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.
8
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
9
Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.胸部计算机断层扫描在 2019 年冠状病毒病(COVID-19)中的表现:与感染持续时间的关系。
Radiology. 2020 Jun;295(3):200463. doi: 10.1148/radiol.2020200463. Epub 2020 Feb 20.
10
The Novel Coronavirus: A Bird's Eye View.新型冠状病毒:概览
Int J Occup Environ Med. 2020 Apr;11(2):65-71. doi: 10.15171/ijoem.2020.1921. Epub 2020 Feb 5.